Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics
Part of paid clinical trials in Hanover, New Hampshire.
- Sponsor
- Square2 Systems, Inc.
- Study ID
- NCT07104396
- Status
- Recruiting
Conditions
- Substance Use Disorders (SUDs)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Cogito digital therapeutics development platform — OTHERCogito will provide a turnkey solution for rapidly developing, evaluating, deploying, and scaling digital therapeutics for the prevention, treatment and/or management of any disease or disorder. This platform will allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide all the components for building a digital therapeutic for any health condition and population. Overall, Cogito offers great promise to markedly accelerate the pace and impact of science based digital therapeutics.
Study Details
This is a research study to evaluate the usability of the Cogito digital therapeutics development platform. The Cogito platform is designed to allow researchers who are seeking to embed an evidence-based behavioral therapy into a digital delivery platform to do so via a drag and drop interface with no programming skills necessary. It will provide the components for building a digital therapeutic for any health condition and population. And in this initial study, the research team plans to examine the usability of Cogito in building a digital therapeutic for substance use disorders (SUDs).
Key Dates
- Start date
- Jul 2, 2025
- Status verified
- Aug 2025
- Primary completion
- Aug 31, 2025
- Completion
- Aug 31, 2025
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
System Usability Scale [ Time Frame: To be completed immediately after usability feedback session ]
Central Contacts
- Square2 Systems(802) 526-4608
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Square 2 Systems | Hanover | New Hampshire | 03755 | Research Coordinator (802) 526-4608 |
Find similar trials in Hanover, NH
Related Studies
- Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of FentanylEnrolling By Invitation · National Institute on Drug Abuse (NIDA) · Baltimore, Maryland